Archive · 26 Jul 2025
Tata 1mg Focuses on B2B Expansion, Delivery Speed in Competitive Market
Tata 1mg, an online pharmacy and diagnostics company, is focusing on selling its services to other businesses.
This B2B side of the company is growing rapidly.
They are also opening more stores and labs to make it easier for people to access their services, even if they don't like ordering online.
The company is also working to deliver medicines quickly, like some other new companies.
However, Tata 1mg is being careful and not rushing into super-fast deliveries.
The company's sales are up, but they still have some losses.
They are experimenting with faster deliveries, but not aggressively.
Tata 1mg is focusing on its enterprise B2B business, which accounts for 30% of revenue.
The company is expanding diagnostics lab centers and retail stores, reaching 126 stores across 10 cities.
Tata 1mg's consolidated revenue rose 22% to ₹2,392 crore in FY25, with losses narrowing to ₹276 crore.
The company is working on quick medicine delivery in major cities, with a median delivery time of 25 minutes in Gurugram.
Tata 1mg is taking a cautious approach to faster deliveries, unlike competitors.
- Who
- Tata 1mg, an online pharmacy and diagnostics platform.
- What
- Tata 1mg is prioritizing its enterprise business and faster medicine delivery.
- When
- FY25 showed revenue growth and a narrowed loss.
- Where
- The company is expanding its retail stores and lab network across multiple cities.
- Why
- To bolster growth and adapt to competition in the quick medicine delivery market.
- Revenue (FY25)
- ₹2,392 crore
- Loss (FY25)
- ₹276 crore
- B2B Revenue
- 30%
- Retail stores
- 126 across 10 cities
- Median delivery time
- 25 minutes (Gurugram)